Role of Vascular Endothelial Growth Factor T Lymphocytes of Mammary Tumor Bearers : Up-Regulation of Matrix Metalloproteinase-9 in

[1]  D. Carbone,et al.  VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. , 2003, Blood.

[2]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[3]  D. Hanahan,et al.  Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells , 2003, The Journal of experimental medicine.

[4]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[5]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[6]  L. Matrisian,et al.  Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.

[7]  Christopher J. Robinson,et al.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.

[8]  L. Boise,et al.  CD30 Signals Integrate Expression of Cytotoxic Effector Molecules, Lymphocyte Trafficking Signals, and Signals for Proliferation and Apoptosis1 , 2000, The Journal of Immunology.

[9]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[10]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[11]  S. Rafii,et al.  Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. , 2000, The Journal of clinical investigation.

[12]  B. Adkins,et al.  Early Block in Maturation Is Associated with Thymic Involution in Mammary Tumor-Bearing Mice1 , 2000, The Journal of Immunology.

[13]  J. Pelletier,et al.  Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[14]  L. Matrisian,et al.  Matrix metalloproteinases: multifunctional contributors to tumor progression. , 2000, Molecular medicine today.

[15]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[16]  A. Kossakowska,et al.  Matrix Metalloproteinases and Their Tissue Inhibitors - Expression, Role and Regulation in Human Malignant Non-Hodgkin's Lymphomas , 2000, Leukemia & lymphoma.

[17]  G. Pilkington,et al.  The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells , 1999, British Journal of Cancer.

[18]  J. Isner,et al.  Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. , 1999, Circulation.

[19]  J. Keiser,et al.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. , 1998, Circulation research.

[20]  S. Shapiro,et al.  Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.

[21]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[22]  X. Cheng,et al.  CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine. , 1998, Journal of immunology.

[23]  S. Reddy,et al.  Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues. , 1998, Gene.

[24]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[25]  F. Aoudjit,et al.  Gelatinase B (MMP‐9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma , 1997, International journal of cancer.

[26]  G. Marti,et al.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. , 1997, Blood.

[27]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[28]  X. Cheng,et al.  Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors. , 1996, Anticancer research.

[29]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.

[30]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[31]  K. Iijima,et al.  Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. , 1996, Journal of immunological methods.

[32]  A. Koch,et al.  Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[33]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[34]  L. Matrisian,et al.  Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. , 1996, The American journal of pathology.

[35]  B. Nielsen,et al.  92 kDa type IV collagenase (MMP‐9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer , 1996, International journal of cancer.

[36]  E. Goetzl,et al.  Matrix metalloproteinases in immunity. , 1996, Journal of immunology.

[37]  S. Hauser,et al.  Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[39]  E. Waubant,et al.  T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.

[40]  J. Dayer,et al.  Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. , 1995, Journal of immunology.

[41]  S. Kaul,et al.  Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts. , 1994, Biochimica et biophysica acta.

[42]  Diana,et al.  Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine , 1994, The Journal of experimental medicine.

[43]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[44]  P. Petrides,et al.  Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. , 1994, Blood.

[45]  E. Podack,et al.  Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets. , 1994, Journal of immunology.

[46]  I. Fidler,et al.  Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. , 1994, Journal of immunology.

[47]  H. Schnaper,et al.  Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B) , 1993, Journal of cellular physiology.

[48]  G. Opdenakker,et al.  Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. , 1993, European journal of biochemistry.

[49]  Brygida Berse,et al.  Vascular permeability factor (VPF, VEGF) in tumor biology , 1993, Cancer and Metastasis Reviews.

[50]  T. Quinn,et al.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Merberg,et al.  Molecular cloning of murine FLT and FLT4. , 1993, Oncogene.

[52]  H. Zhou,et al.  Induction of metalloproteinase activity in human T-lymphocytes. , 1993, Biochimica et biophysica acta.

[53]  H. Tanaka,et al.  Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[54]  E. Manseau,et al.  Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.

[55]  A. Strongin,et al.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.

[56]  L. Liotta,et al.  Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.

[57]  L. Liotta,et al.  Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.

[58]  L. Liotta,et al.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.

[59]  J. Jimenez,et al.  Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. , 1990, Cancer research.

[60]  L. Liotta,et al.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.

[61]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[62]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[63]  A. Miller,et al.  Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocaricinoma. i. characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity , 1984, International journal of cancer.

[64]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[65]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[66]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[67]  D. Medina,et al.  Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. , 1969, Journal of the National Cancer Institute.

[68]  L. Liotta,et al.  Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas , 2004, Clinical & Experimental Metastasis.

[69]  L. Jing.  Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis , 2001 .

[70]  D. Lopez,et al.  Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha. , 2000, International journal of oncology.

[71]  T. Grogan,et al.  Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. , 1999, Blood.

[72]  D. Lopez,et al.  Altered binding of the NF-GMa transcription factor is involved in the upregulated production of TNF-alpha by macrophages of mammary tumor bearing mice. , 1998, International journal of molecular medicine.

[73]  H. Birkedal‐Hansen.  Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[74]  B. Imhof,et al.  Leukocyte migration and adhesion. , 1995, Advances in immunology.

[75]  E. Sotomayor,et al.  Modulation of the immune system by mammary tumor-derived factors. , 1991, Cancer investigation.

[76]  L. Liotta,et al.  Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.

[77]  S. Rosenberg,et al.  Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans. , 1990, Important advances in oncology.